跳至主要内容
临床试验/ACTRN12613000396729
ACTRN12613000396729尚未招募未知

Efficacy and safety of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Kobeni (province of Hodh El Gharbi) and Timbedra (province of Echargui), Mauritania

Ministry of Health Mauritania0 个研究点目标入组 120 人开始时间: 2013年4月11日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
6 Months 至 o limit(—)
性别
All

入选标准

  • 6 months and older
  • microscopically confirmed mono-infection with P falciparum
  • parasitaemia between 250 and 100,000 asexual parasites/microliter
  • axillary temperature greater or equal to 37.5 degrees Celsius or history of fever within the past 24 hours
  • able to swallow medication
  • able to comply with the protocol and schedule of assessments

排除标准

  • presence of general danger signs in children aged under 5 years or signs of severe falciparum malaria according to the definitions of WHO
  • mixed infection with another plasmodium species detected my microscopy
  • presence of severe malnutrition
  • presence of febrile conditions due to diseases other than malaria (e.g. measles, acute lower respiratory tract infection, severe diarrhoea with dehaydration) or other known underlying chronic or severe diseases
  • regualr medication tha tmight interfere with antimalrial pharmacokinetics
  • history of hypersensitivity reactions or contraindications to any medicines being tested or used as alternative treatments,
  • positive pregnancy test or breast feeding in married women
  • adolecents between 12 and 18 or unmarried single women in whom pregnancy test may not be performed.

研究者

发起方
Ministry of Health Mauritania

相似试验